2022
DOI: 10.1016/j.jscs.2022.101473
|View full text |Cite
|
Sign up to set email alerts
|

In-silico investigation of phenolic compounds from leaves of Phillyrea angustifolia L. as a potential inhibitor against the SARS-CoV-2 main protease (Mpro PDB ID:5R83) using a virtual screening method

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 41 publications
(36 reference statements)
0
4
0
Order By: Relevance
“…Chemical treatments have always been popular because of their immediate action against the ailment they are meant to treat ( Moon and Alam, 2020 ). Herbal medications also have been chastised for their sluggish action on the human body ( Abdalla et al, 2021 , Boufissiou et al, 2022 ). Additionally, herbal medications have a big advantage in terms of their benign nature, which means they are far less likely to harm humans.…”
Section: Introductionmentioning
confidence: 99%
“…Chemical treatments have always been popular because of their immediate action against the ailment they are meant to treat ( Moon and Alam, 2020 ). Herbal medications also have been chastised for their sluggish action on the human body ( Abdalla et al, 2021 , Boufissiou et al, 2022 ). Additionally, herbal medications have a big advantage in terms of their benign nature, which means they are far less likely to harm humans.…”
Section: Introductionmentioning
confidence: 99%
“…C-5 and C-8 were put through molecular dynamics (MD) simulations to ascertain the stability of the ligand-protein interactions, which served to further establish their potential as therapeutic leads (62). Additionally, research was done to evaluate the pharmacokinetics, drug-likeness, and quantitative structure-activity relationship (QSAR) of these compounds (63). The findings revealed that C-5 had the best pharmacokinetic and drug-like characteristics, making it a good candidate for further development and optimization as a medication to treat COVID-19 (64).…”
Section: Computational Methods For Sars-cov-2 Protease Inhibitor Iden...mentioning
confidence: 99%
“…The crystal structure of COVID-19 main protease (PDB 6LU7) in complex with an inhibitor N3 was also used. All proteins were preprocessed than targeted for molecular binding with the compound as previously described [30][31][32]. Preprocessing includes removing water molecules and adding polar hydrogen and Coleman charges [33,34].…”
Section: In Silico Molecular Docking Druggability and Pharmacokineticsmentioning
confidence: 99%